Abstract
Background: High-risk cases for NAFLD are currently underreported or not identified in a timely manner. It is important to elucidate the clinical behavior of the interaction of clinical values in metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD), considering the complications that may occur in the group of patients with this comorbidity.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
